- Home
- IRMD vs CBLL Comparison
IRMD vs CBLL Comparison
Compare IRMD & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRMD
- CBLL
- Stock Information
- Founded
- IRMD 1992
- CBLL 2014
- Country
- IRMD United States
- CBLL United States
- Employees
- IRMD N/A
- CBLL N/A
- Industry
- IRMD Medical/Dental Instruments
- CBLL
- Sector
- IRMD Health Care
- CBLL
- Exchange
- IRMD Nasdaq
- CBLL Nasdaq
- Market Cap
- IRMD 756.5M
- CBLL 710.2M
- IPO Year
- IRMD 2014
- CBLL 2024
- Fundamental
- Price
- IRMD $70.38
- CBLL $12.31
- Analyst Decision
- IRMD Strong Buy
- CBLL Strong Buy
- Analyst Count
- IRMD 1
- CBLL 6
- Target Price
- IRMD $72.00
- CBLL $33.00
- AVG Volume (30 Days)
- IRMD 56.2K
- CBLL 340.8K
- Earning Date
- IRMD 08-01-2025
- CBLL 08-05-2025
- Dividend Yield
- IRMD 0.97%
- CBLL N/A
- EPS Growth
- IRMD 10.28
- CBLL N/A
- EPS
- IRMD 1.61
- CBLL N/A
- Revenue
- IRMD $77,635,163.00
- CBLL $77,419,000.00
- Revenue This Year
- IRMD $10.62
- CBLL $33.98
- Revenue Next Year
- IRMD $9.69
- CBLL $28.82
- P/E Ratio
- IRMD $43.72
- CBLL N/A
- Revenue Growth
- IRMD 11.73
- CBLL 42.16
- 52 Week Low
- IRMD $43.17
- CBLL $10.01
- 52 Week High
- IRMD $73.47
- CBLL $32.75
- Technical
- Relative Strength Index (RSI)
- IRMD 67.36
- CBLL N/A
- Support Level
- IRMD $69.44
- CBLL N/A
- Resistance Level
- IRMD $73.47
- CBLL N/A
- Average True Range (ATR)
- IRMD 2.54
- CBLL 0.00
- MACD
- IRMD 0.58
- CBLL 0.00
- Stochastic Oscillator
- IRMD 80.61
- CBLL 0.00
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
About CBLL CeriBell Inc. Common Stock
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.